"Pardubická nemocnice je součástí společnosti Nemocnice Pardubického kraje, a. s. Ta se s ročním obratem více než 3,5 miliardy korun a zhruba 4 600 zaměstnanci řadí mezi desítku největších nemocnic v zemi. Společnost tvoří pět pracovišť: • Pardubická nemocnice • Chrudimská nemocnice • Orlickoústecká nemocnice • Litomyšlská nemocnice • Svitavská nemocnice"

During the past decade, Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" #1 sponsor was "Amgen" with 2 trials, followed by "Biogen" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" #1 collaborator was "Association for Functional Rehabilitation, Recreation and Applied Kinesiology Impulse" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" are "Multiple Sclerosis" (2 trials), "Acute Myocardial Infarction" (1 trials), "Acute Non-cardioembolic Ischemic Stroke" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" in a lesser frequency.

Most popular intervention types in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" are "Drug" (8 trials), "Other" (3 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Nemocnice Pardubickeho kraje, a.s. Pardubicka nemocnice has several departments that took part in Clinical trials: "Krajska Nemocnice Pardubice Neurologicka Klinika" - 7 trials, "Dermatovenerologicka ambulance" - 5 trials